Cargando…
Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis
This study was conducted to estimate the indirect costs and health-related quality of life (HRQoL) (utilities) of multiple sclerosis (MS) patients in the United States (US), and to determine the impact of worsening mobility on these parameters. In collaboration with the North American Research Commi...
Autores principales: | Coleman, Craig I., Sidovar, Matthew F., Roberts, Matthew S., Kohn, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552958/ https://www.ncbi.nlm.nih.gov/pubmed/23355896 http://dx.doi.org/10.1371/journal.pone.0054756 |
Ejemplares similares
-
Estimating a minimal clinically important difference for the EuroQol 5-dimension health status index in persons with multiple sclerosis
por: Kohn, Christine G, et al.
Publicado: (2014) -
Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients
por: Sidovar, Matthew F, et al.
Publicado: (2013) -
Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients
por: Limone, Brendan L, et al.
Publicado: (2013) -
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort
por: Sidovar, Matthew F, et al.
Publicado: (2016) -
Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program
por: Crayton, Heidi, et al.
Publicado: (2014)